Evaluation of the Effectiveness of Ischemic Pre-conditioning on the Morbidity and Mortality of Open Surgery of Thoracoabdominal Aortic Aneurysms. (EPICATA)
Patients having a planned open surgery of thoracoabdominal aortic aneurysms and enrolled in the study will be randomized the day of the surgery in 2 groups:
- Arm 1 : Patients with aortic clamping with pre-conditioning
- Arm 2 : Patients with aortic clamping without pre-conditioning Patients will be then followed, during 60 days after surgery.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rouen, France, 76031
- University Hospital, Rouen
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient > 18 and <85 years old
- Patient having a planned surgery for a thoracoabdominal aortic aneurysm by direct approach,
- Patient with aortic aneurysm requiring supra-visceral aortic clamping and visceral artery reconstruction,
- Aortic aneurysmal patient with or without distal femoral circulatory assistance,
- Patient with aortic aneurysm of atheromatous or dissecting etiology,
- Woman of childbearing potential with effective contraception (estrogen-progestin or intrauterine device or tubal ligation), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy)
- Patient who read and understood the newsletter and signed the consent form
- Patient affiliated with a social security scheme
Exclusion Criteria:
- Patient with aortic aneurysms requiring supra-visceral aortic clamping but not requiring visceral artery reconstruction (supra-visceral aortic clamping for renal aortic juxtaposition aorta),
- Patient with thoraco abdominal aortic aneurysms requiring a circulatory arrest (aortic aneurysms affecting the descending thoracic aorta or the aortic arch)
- Patient requiring emergency aortic surgery
- Patient under treatment known as interfering with PCI (Nicorandil or oral antidiabetic agents),
- Pregnant or lactating woman (negative result of baseline blood test)
- Participation in another interventional study within 28 days before randomization or during this study
- Person deprived of liberty by an administrative or judicial decision or person subject to a legal measure for the protection of adults,
- Patient under the protection of justice, patient under guardianship or curatorship.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Arm 1
Patients with aortic clamping withpre-conditioning
|
PCI procedure: clamping of the supracellular thoracic aorta for 5 minutes followed by a 5-minutes de-clamping period. PCI procedure is repeated twice. |
|
No Intervention: Arm 2
Patients with aortic clamping without pre-conditioning
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
occurrence of a pulmonary complication
Time Frame: Before the 48 hours after the beginning surgery
|
Need for prolonged invasive ventilation
|
Before the 48 hours after the beginning surgery
|
|
occurrence of a kidney complication
Time Frame: During the 8 days after surgery
|
According to RIFLE criteria
|
During the 8 days after surgery
|
|
occurrence of a pulmonary complication
Time Frame: During the 8 days after surgery
|
Occurrence of a moderate or severe acute respiratory distress syndrome (Berlin definition)
|
During the 8 days after surgery
|
|
occurrence of a pulmonary complication
Time Frame: During the 48 hours after initial extubation
|
Need for a new ventilation (invasive or not)
|
During the 48 hours after initial extubation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulmonary Morbidity
Time Frame: During the 21 days after surgery
|
Need of a new ventilation (invasive or not)
|
During the 21 days after surgery
|
|
Kidney Morbidity
Time Frame: During the 21 days after surgery
|
According to RIFLE criteria
|
During the 21 days after surgery
|
|
Cardiac Morbidity
Time Frame: During the 48 hours after surgery
|
Value of troponin
|
During the 48 hours after surgery
|
|
cell and tissue damage
Time Frame: During the 8 days after surgery
|
Value of D Lactate
|
During the 8 days after surgery
|
|
Death
Time Frame: During 60 days after surgery
|
During 60 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Palmier M, Bubenheim M, Chiche L, Chaufour X, Koskas F, Fadel E, Magnan PE, Ducasse E, Chakfe N, Steinmetz E, Dusseaux MM, Ricco JB, Plissonnier D. Protocol of supra-visceral aortic ischemic preconditioning for open surgical repair of thoracoabdominal aortic aneurysm : The EPICATA study (Evaluation of the Efficacy of Ischemic PreConditioning on morbidity and mortality in open ThoracoAbdominal Aortic surgery). BMC Surg. 2020 Aug 27;20(1):193. doi: 10.1186/s12893-020-00851-3.
- Liang F, Liu S, Liu G, Liu H, Wang Q, Song B, Yao L. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD008472. doi: 10.1002/14651858.CD008472.pub3.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2017/388/HP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.